ULTRAGENYX PHARMACEUTICAL INC. Treasury Stock, Shares
ULTRAGENYX PHARMACEUTICAL INC. (RARE) had Treasury Stock, Shares of 7.81 thousand shares as of 2023-03-31, per its 10-Q filed 2023-05-05.
Discontinued › Notes
us-gaap:TreasuryStockShares · last filed 2023-05-05
- 2023-03-31: Treasury Stock, Shares 7.81K shares.
- 2022-12-31: Treasury Stock, Shares 0.00 shares.
| Period end | Treasury Stock, Shares |
|---|---|
| 2023-03-31 | 7.81K shares 10-Q · filed 2023-05-05 |
| 2022-12-31 | 0.00 shares 10-Q · filed 2023-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |